{{Rsnum
|rsid=2896103
|Gene=DNAH5
|Chromosome=5
|position=13764310
|Orientation=minus
|GMAF=0.2759
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=DNAH5
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 54.7 | 40.6 | 4.7
| HCB | 82.2 | 17.8 | 0.0
| JPT | 65.9 | 31.8 | 2.3
| YRI | 30.2 | 60.3 | 9.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 82.2 | 17.8 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs2896103
|PubMedID=17903303
|Condition=Other subclinical atherosclerosis traits
|Gene=DNAH5
|Risk Allele=
|pValue=5.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs2896103
|Name_s=
|Gene_s=DNAH5
|Feature=
|Evidence=PubMed ID:17903303; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study (Initial Sample Size: 673-984 individuals, depending on measure (Framingham; Replication Sample Size: NR). This variant is associated with Other subclinical atherosclerosis traits.
|Drugs=
|Drug Classes=
|Diseases=Arteriosclerosis; Cardiovascular Diseases; Coronary Disease
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356503
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2896103
|overall_frequency_n=42
|overall_frequency_d=126
|overall_frequency=0.333333
|n_genomes=29
|n_genomes_annotated=0
|n_haplomes=35
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}